Pharmacists in Red Springs, NC Accepting Medicare
8 Pharmacists found. Showing 1 - 8
 Jessica Parker Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 E 4th Ave, Red Springs, NC 28377 Phone: 910-843-3459 |
Dr. Kandice H Baye, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 E 4th Ave, Red Springs, NC 28377 Phone: 910-843-3459 |
Yolanda Ntock Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 E 4th Ave, Red Springs, NC 28377 Phone: 910-843-3459 |
Ji Young Park Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 E 4th Ave, Red Springs, NC 28377 Phone: 910-843-3459 |
 Mr. James Craig Bell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 S Main St, Red Springs, NC 28377 Phone: 910-843-4531 Fax: 910-843-4687 |
Amber Locklear Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 S Main St, Red Springs, NC 28377 Phone: 910-227-2425 |
Dr. Monica Sandoval Oxendine, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 E 4th Ave, Red Springs, NC 28377 Phone: 910-843-3459 Fax: 910-843-1545 |
Dr. Marcia Elizabeth Hooks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 E 4th Ave, Red Springs, NC 28377 Phone: 704-547-4658 |
News Archive
Alzheimer's may be triggered by neuron division
A new study in mice suggests that Alzheimer's disease (AD) may be triggered when adult neurons try to divide. The finding helps researchers understand what goes wrong in the disease and may lead to new ways of treating it.
Pediatric interventions at 1 to 3 age may have the greatest impact at preventing childhood obesity
Columbia researchers have uncovered a critical age when many inner city children become overweight or obese: between the ages of 1 and 3 years old.
Idenix Pharmaceuticals prices underwritten offering of common stock at $4.35 per share
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
Lumeris releases innovative technology platform to improve quality of care delivered to consumers
Lumeris, a leader in provider performance management technology and services for the health care industry, today announced the general market release of its innovative technology platform that helps health plans and other health care delivery organizations reduce the cost and improve the quality of care delivered to consumers.
› Verified 6 days ago